Cardiovascular Diseases during Pregnancy

Pregnancy increases the risk of new-onset SVT. This risk is more in pregnant patients with Wolff-Parkinson-White syndrome. In the absence of structural heart disease, AF and atrial flutter are rare during pregnancy. Non-sustained ventricular arrhythmias takes place in up to 50% of pregnant women, but the clinical risk of sustained ventricular arrhythmia in the absence of structural heart disease is low.

Most antiarrhythmic drugs are divided as category C drugs while pregnancy by the United States Food and Drug Administration (FDA) .Therefore, drug therapy should be used only in patients who have life-threatening arrhythmias or debilitating symptoms. Most β-blockers are classified as category C drugs by the FDA; however, atenolol is classified as a category D drug because it has been implicated in intrauterine growth retardation, and sotalol, pindolol, and acebutolol are classified as category B drugs. The other class C drugs include digoxin, adenosine and heparin, whereas lidocaine and enoxaparin are class B drugs. Enoxaparin is safe for the fetus, but some formulations contain the preservative benzyl alcohol, which can be harmful. Amiodarone is taken as category D drug, and warfarin (category X) should not be used at all during pregnancy because of its teratogenicity.

    Related Conference of Cardiovascular Diseases during Pregnancy

    May 19-20, 2025

    4th International Conference on Cardiology

    Rome, Italy
    May 22-23, 2025

    5th World Congress on Congestive Heart Failure & Angina

    Zurich, Switzerland
    May 26-27, 2025

    6th European Summit on Cardiology Research

    Rome, Italy
    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 19-20, 2025

    29th World Cardiology Conference

    Paris, France
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Vienna, Austria
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 19-20, 2025

    7th Euro Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    April 21-22, 2026

    15th World Heart Congress

    Aix-en-Provence, France

    Cardiovascular Diseases during Pregnancy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in